While a newly published opinion piece suggests the incoming commissioner lacks a basic grasp of administrative power, the medical community urged the public not to panic without longitudinal data.
The findings, published this week by former FDA official Joshua Sharfstein, assert that Makary’s “norm-shattering” approach to public health masks a deeper inability to comprehend how to enact lasting bureaucratic change. However, leading methodologists immediately pushed back on the piece, noting that Sharfstein’s conclusions rely on an observational cohort of just one cabinet nominee and completely lack a randomized control group of alternative administrative disasters.
Researchers stressed that while the correlation between Makary’s stated intent to gut the agency and the actual end of domestic food and drug safety standards appears strong on paper, causation remains entirely unproven. Experts noted that confounding variables—such as pre-existing institutional rot, comorbid Senate confirmations, or naturally occurring variations in regulatory capture—could easily account for the FDA’s projected failure.
While Sharfstein’s diagnosis of a fundamental misunderstanding is compelling, we simply do not have the longitudinal data necessary to declare the federal regulatory apparatus dead upon arrival.
Dr. Vance added that the “norm-shattering” symptoms described in the op-ed are largely self-reported by the incoming administration and have not yet been replicated in a double-blind, peer-reviewed environment. Until a second, independent study allows a completely different federal agency to be dismantled under identical laboratory conditions, the true efficacy of Makary’s misunderstanding cannot be clinically verified.
In the interim, public health officials recommend a standard dose of caution. Citizens are advised to continue monitoring their own food and drug supplies for unapproved adulterants, as the most severe side effects of a fundamentally misunderstood FDA are not expected to reach statistical significance until well into the next fiscal year.